Omni Bridgeway Ltd Overview
Omni Bridgeway describes itself as the leading global alternative asset manager dedicated to legal assets. Its activities are:
-
originating, underwriting and managing investments in commercial litigation, class/group actions, international arbitration, judgment and award enforcement, and distressed and non-performing asset recovery;
-
doing so across more than 15 countries and both common-law and civil-law systems.
Following the December 2024 to April 2025 Fund 9 continuation-fund transaction with Ares Management, the company changed its capital model. It moved from a balance-sheet-heavy, net-debt-funded co-investor to a capital-light fund manager. It now earns management, transaction and service fees and carried interest on third-party capital, while retaining co-investment exposure. At 30 June 2026 it was debt-free at the corporate level, managed A$5.9bn of AUM and held interests in more than 300 active litigation investments.
Its competitive claim rests on three things: a 40-year realised track record (FY26 MOIC 2.3x; five-year trailing IRR 40%), unusual jurisdictional breadth, and an enforcement and asset-recovery capability few funders possess. The core investment debate is converting this platform into durable, fee-covered, per-share earnings growth.
Company's own description (FY26 Annual Report)
The FY26 Annual Report defines the Group's principal activities as "the management of, and co-investment into funds or other investment structures that are focused on legal finance and the investment in legal assets globally."
The Group invests through four types of agreement:
-
financing,
-
purchase,
-
monetisation, or
-
risk-sharing.
Its counterparties are claimants, liquidators, banks, creditors and law firms, in relation to legal claims, awards, judgments and non-performing loans, either standalone or on a portfolio basis. Overlaying this is an asset-management layer that services third-party capital, generates management, service and transaction fees, and provides carried-interest upside.
The report names three core operations:
-
Litigation and Arbitration Funding. Capital provided to claimants and law firms for high-value commercial disputes, class actions and international arbitrations. Returns depend on settlement, judgment or award.
-
Legal Enforcement and Asset Recovery. Funding the enforcement and/or monetisation of claims, judgments and awards, especially cross-border. This includes distressed and non-performing assets.
-
Investment Management. Acting as investment adviser to multiple funds and structures, earning:
-
transaction fees (e.g., Funds 4/5 Series II),
-
management fees (all funds except Fund 1 and Funds 2&3), and
-
carried interest (Funds 6 and Funds 4/5 Series I and II).
-
Revenue model
| Revenue stream | Nature | Template analogue | FY26 evidence (source) |
|---|---|---|---|
| Investment proceeds / fair-value gains on co-investments | Principal investment returns. These are lumpy and outcome-contingent; typically the investment plus a multiple of capital or a % of recovery, often escalating with duration. | Closest to "product" or principal income | Net gain on litigation investments (financial assets) A$61.9m; gross proceeds and investment revenue A$105.6m (FY26 AR) |
| Management fees | Recurring fees on net deployed or committed third-party capital, recognised quarterly in arrears | Closest to "subscription" | Management fees A$35.4m (FY26 4Q report); management fee cash proceeds A$28.8m (FY26 AR cash flow) |
| Transaction and service fees | Underwriting and monitoring fees (e.g., Funds 4/5 Series II) | Service | Included in "management, service and transaction fees" of A$27.3m statutory revenue (FY26 AR Note 2) |
| Carried interest | Profit share above fund hurdles; American-waterfall funds pay earlier | Performance fee | Cash carried interest A$6.6m (FY26 4Q report) |
| Claims-portfolio enforcement revenue | Percentage-of-recovery fees on enforcement and recovery services (largely EMEA) | Service (success-fee) | A$69.0m (FY26 AR Note 2) |
| Interest revenue | Mainly on purchased claims | Financial | A$10.2m (FY26 AR Note 3) |
The template's product/service/subscription/licensing split maps onto Omni Bridgeway's economics as follows:
Analyst characterisation. On FY26 numbers, OBL is a hybrid. It is roughly 25–35% a fee-earning manager, measured by fee income relative to total statutory income. The remainder is an outcome-contingent principal investor. Management's stated objective is to raise the fee share: cost coverage, defined as fee income over cash operating expenses, rose from 36% in FY25 to 53% in FY26. Management has signalled a 70% cost-coverage target by 2028 (1H26 results commentary as reported by investing.com). The model is "capital-light" in that most new deployments are funded by third parties: OBL-only deployments were A$28.3m of A$241.8m total in FY26, about 12%.
Value-chain position, customer types and end-markets
OBL sits between capital providers and legal-claim owners:
Capital providers: include institutional LPs, Ares (Fund 9), insurers providing ATE and capital-protection wrap, and sidecar investors.
Claim owners: include corporates, insolvency practitioners, law firms, class members, sovereign creditors and banks holding NPLs.
The company's website identifies three client groups: law firms (portfolio and firm-level financing), companies (single-case and portfolio monetisation) and bankruptcy/insolvency professionals.
End-markets served:
-
commercial disputes,
-
international arbitration (including investor-state),
-
intellectual property (US patent),
-
investor recoveries and securities class actions (non-US group actions),
-
appeals,
-
whistleblower claims,
-
bankruptcy,
-
judgment enforcement, and
-
distressed asset recovery (company website "Solutions" taxonomy).
Independent characterisation. The economic engine is underwriting skill (probability, duration, budget, quantum and recoverability), combined with a fund structure that monetises that skill on others' capital. The key sensitivities are:
-
duration, which dilutes IRRs;
-
FX, since most assets are USD/EUR-denominated against an AUD reporting currency (FY26 OCI loss A$48.7m); and
-
realisation timing, which management explicitly declines to forecast.
Strategy
Stated strategy (themes from FY25–FY26 reporting)
Management summarises the arc as "FY25 was a year of transformation, FY26 was a year of execution." The FY26 Remuneration Report and results materials articulate four strategic priorities:
-
Improving cost coverage: growing fee income relative to cash opex.
-
Expanding and diversifying the legal-assets portfolio: record A$712.2m of commitments in FY26.
-
Maintaining strong investment performance: MOIC 2.3x, fair-value conversion 105%, five-year trailing IRR 40%.
-
Broadening third-party capital sources: flagship funds, continuation funds, sidecars and structured solutions.
The positioning theme is that the industry is "consolidating around a small number of institutional-grade platforms." Management argues that a four-decade track record is the hardest asset to replicate (CEO, FY26 release).
Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description | Targets / outcome |
|---|---|---|---|
| Fund 9 continuation fund with Ares | Dec 2024 – Apr 2025 | Sale of 70% of co-investments in 150+ assets | ~A$320m cash; debt repaid; ~A$30m annual interest saved (ShareCafe) |
| Capital-light transition and deconsolidation | FY25 | Reporting aligned with asset-management peers; deconsolidation of Funds 2&3 and Fund 4 Series I&II | Completed |
| Capital formation team | Mar 2025 | Dedicated team coordinating fund raising | US$1bn Funds 4/5 Series II target reached in Aug 2026 |
| Opex reduction programme | FY25–FY26 | FY25 target A$85m; FY26 budget A$80m | FY26 actual A$67.1m (16% under budget) |
| Fee income targets | FY26 | FY26 target A$35m (upgraded) | A$35.4m achieved |
| Cost coverage target | Disclosed 1H26 | 70% cost coverage by 2028 (investing.com summary of 1H26 results) | FY26: 53% |
| Sidecar and structured capital | FY26 | Fee-paying sidecars; structured solutions | A$72.5m raised; ~A$175m in diligence |
| Head of Commercial Strategy & Capital Solutions | Apr 2026 | New York-based role for large structured financings | Hire completed |
| Introduction to Omni Bridgeway and Analyst Data Pack | 26 Mar 2026 | Enhanced transparency for analysts | Released |
| Team Carried Interest Plan | FY26 | Carry-based remuneration replacing STI/LTI for investment staff | 84 participants |
| Executive Plan | AGM Oct 2026 | Performance rights with TSR, ROE and AUM-growth hurdles | Subject to shareholder vote |
| AI-driven efficiencies | 1H26 commentary | Referenced in the 1H26 call summary as supporting the outlook | No quantified target disclosed |
Medium-term targets and guidance
| Target | Current position |
|---|---|
| 70% cost coverage by 2028 | 53% in FY26 |
| Continued fee-income growth as AUM scales | Fee income +17% in FY26 |
| Opex discipline | — |
| Executive Plan ROE hurdle | 12.5–17.5% |
| Executive Plan AUM growth hurdle | 5–12.5% a year |
The company does not provide earnings forecasts because completion timing is uncertain (FY26 AR, "Likely developments"). Quarterly reports instead give indications of completion values and estimated new commitments.
Explicit or implied operating targets:
ESG and sustainability: no quantified commitments were found.
Products & Services
Omni Bridgeway has no physical products, patents-as-products or software platforms. Its "products" are financing solutions and fund vehicles. Pricing is negotiated case by case: typically a multiple of capital deployed, a percentage of proceeds, or the greater of the two, usually escalating with duration (FY26 AR). Specific price grids are not publicly disclosed.
Financing solutions (client-facing)
| Solution | Description and capabilities | Target customer | Pricing model | Status |
|---|---|---|---|---|
| Dispute Funding – Commercial | Non-recourse funding of fees and costs for high-value commercial claims; single-case or portfolio | Corporates, claimants, law firms | Multiple and/or % of proceeds; escalators | Core, all regions |
| Dispute Funding – Intellectual Property | Patent and IP litigation funding, mainly US | Patent owners, IP firms | As above | Chambers Band 1 US IP (2025) |
| Dispute Funding – Investor Recoveries | Securities and investor loss claims | Institutional and retail investors | As above | Active |
| Dispute Funding – Class/Group Actions (non-US) | Australian, Canadian, NZ, European group actions. Funding commission is often court-supervised; adverse-cost cover is provided. | Class members, plaintiff firms | Court-approved commission | APAC flagship (e.g., co-funding of Medibank data-breach class action, BHP and Rio Tinto discrimination actions, and an ESSSuper entitlements action per Business News Australia, Apr 2025) |
| Dispute Funding – Appeals | Funding of appellate stages; may include monetisation of judgments under appeal | Judgment holders | Multiple / discount | Active |
| Dispute Funding – Whistleblower | Funding of whistleblower claims (e.g., qui tam) | Whistleblowers and counsel | % of recovery | Active |
| Dispute Funding – Bankruptcy | Funding for trustees and liquidators to pursue estate claims | Insolvency professionals | % of recovery | Heritage IMF franchise |
| Arbitration Financing | Commercial and investor-state arbitration funding, including award monetisation | Corporates, sovereign creditors | As above | Chambers Band 1 International Arbitration (2020–2025) |
| Judgment Enforcement | Funding and running enforcement of judgments and awards, including against sovereigns; asset tracing and intelligence | Award and judgment creditors, ECAs, insurers | Success fee / purchase | Chambers Band 1 Global Asset Tracing & Recovery (2020–2025) |
| Distressed Asset Recovery | NPL enforcement, subrogation claims for insurers, purchased claims. Includes the IFC JV (DARP). | Banks, insurers, multilaterals | Purchase price discount / % of recovery | EMEA-led |
| Law Firm Financing | Portfolio and firm-level facilities | Law firms | Portfolio terms | Active |
| Adverse-cost cover / ATE capability | Coverage of client adverse-cost exposure in loser-pays jurisdictions, using insurance | Claimants in AU, UK, EU, CA | Embedded in funding terms | Active |
| Structured finance and alternative investment solutions | Large-scale structured legal-asset financings and sidecars; led from New York by Peter Galgay since April 2026 | Institutional investors and large claim holders | Bespoke | New initiative; A$72.5m sidecar capital raised in FY26, ~A$175m in diligence |
Fund and investment vehicles (investor-facing)
| Vehicle | Description | Fees to OBL | Key disclosed facts | Status |
|---|---|---|---|---|
| Fund 1 | US-focused legacy fund | No management fee (FY26 AR) | Size not re-verified | Harvesting |
| Funds 2 & 3 | Legacy APAC/RoW funds | No management fee | OBL co-investment sold into Fund 9; deconsolidated FY25 | Harvesting |
| Funds 4/5 Series I | Global flagship series | Management fees; carried interest | OBL co-investment sold into Fund 9; Fund 4 Series I deconsolidated FY25 | Harvesting |
| Funds 4/5 Series II | Current global flagship | Transaction fees; management fees; carried interest | US$1bn raise target achieved post-FY26. Includes >US$300m of subscriptions on substantially agreed terms pending documentation. US$228m closed in 1H26. | Investing |
| Fund 6 | Fund with carried interest to OBL | Management fees; carried interest | Size not re-verified | Investing/harvesting |
| Fund 8 | Enforcement-focused fund (target €300m) using insured, non-recourse debt | Management fees | First tranche €135m (Sep 2023). Facility non-recourse to OBL beyond insurance, Fund 8 assets and a capped standby equity commitment. A$35.4m borrowings consolidated at 30 June 2026. | Investing |
| Fund 9 (Continuation Fund) | First continuation fund for legal assets. Holds OBL's former co-investments in 150+ assets. Ares 70%, OBL 30%. | Management fees (FY25 3Q report referenced fee arrangements); Ares has a preferred return | ~A$320m paid to OBL for Ares' 70% | Harvesting |
| Sidecars | Fee-paying co-investment vehicles alongside funds | Separately agreed management fees and carried interest | A$72.5m raised FY26 | Growing |
| DARP (with IFC) | JV programme for NPL enforcement in emerging markets | — | — | Active (status not re-verified) |
Financial Narrative
How to read OBL's financials
Three accounting features make conventional metrics unreliable:
-
Fund consolidation. Fund consolidation, and the FY25 deconsolidation, produce large non-controlling interests (NCI). "Profit for the year" therefore differs from "profit attributable to members". FY26: A$45.9m versus A$53.7m.
-
Mixed measurement. Litigation investments are carried partly at fair value through profit or loss (12% discount rate; FY26 AR) and partly at cost, as intangible assets or claims portfolio. Statutory "revenue" therefore excludes most investment returns.
-
Third-party definitions. S&P Global's standardised "revenue", "gross profit" and "operating income" do not correspond to company definitions and should be read as indicative only.
Company-reported figures are used wherever available and labelled; S&P-standardised figures are labelled "S&P".
Company-defined income metrics (FY24–FY26)
FY24 values are back-calculated from the reported FY25 percentage changes: total income +253%, profit +1267%, revenue -18%. FY24 NCI is derived as profit after tax less attributable loss.
Margins (S&P definitions; indicative only)
Revenue CAGR. On S&P-standardised revenue, the FY22–FY26 CAGR is ≈37.9% (A$31.0m to A$112.3m). This is not economically meaningful, because "revenue" excludes most investment returns. A more meaningful growth metric is fee income: A$25m (FY24) to A$35.4m (FY26), a ≈19% two-year CAGR.
Margin commentary. Net margin on total income is a better gauge than S&P margins:
-
FY26: 25.2% (A$45.9m / A$182.2m)
-
FY25: 64.0%, distorted by Fund 9
-
FY24: ≈16.5%
The structural improvement is on the cost side:
-
Employee costs fell A$10.0m.
-
Professional fees fell from A$11.3m to A$4.4m, as FY25 Fund 9 deal costs did not recur.
-
Finance costs fell from A$11.1m to A$1.3m after debt repayment.
Balance sheet
Sources and notes:
-
FY25–FY26 are from the FY26 AR. FY22–FY24 are from S&P Global via StockAnalysis.
-
FY22 borrowings were classified as current, as the facility was maturing.
-
FY26 is presented on an unclassified basis in the statutory accounts, so the short/long split is not available. The company's working-capital analysis gives current assets of A$224.4m and current liabilities of A$131.9m.
Litigation investments carrying value: A$652.0m at 30 June 2026 versus A$628.1m at FY25. The FY26 breakdown is:
-
financial assets at FVTPL: A$473.0m
-
claims portfolio: A$90.4m
-
intangible assets: A$62.0m
-
purchased claims: A$26.6m
-
investment in associates: A$1.1m
Other notable liabilities (FY26):
-
Fund 9 warrants liability: A$29.5m (FY25: A$22.9m). Management expects equity settlement.
-
Deferred tax liabilities: A$86.5m, including A$75.3m relating to the Fund 9 transaction.
-
Provisions fell from A$33.1m to A$5.4m.
Cash flow
Sources: FY25–FY26 from the FY26 AR; FY22–FY24 from S&P Global.
Buybacks:
-
FY25: A$10k paid under a share buy-back scheme (FY26 AR comparative).
-
FY26: nil.
Cash flow commentary. IFRS classification splits litigation cash flows between operating (claims portfolio) and investing (intangibles, purchased claims, financial assets). OCF and FCF in the conventional sense therefore materially understate economic cash generation. The FY26 aggregate operating plus investing flows included:
-
proceeds from litigation investments: A$138.0m
-
management-fee proceeds: A$28.8m
-
payments for litigation investments: A$80.0m
Management's "OBL-only net cash generation" was +A$22.4m in FY26. Financing flows were near-neutral (-A$0.3m), comprising:
-
A$19.0m Fund 8 drawdown,
-
A$11.2m distributions to NCI, and
-
A$5.2m lease payments.
FY25 financing flows of -A$273.7m reflected the A$250m debt repayment funded by Fund 9 (investing inflow of A$314.1m from disposal of subsidiaries).
Ratios (analyst calculations unless noted)
Notes and other ratios:
Company-defined returns: On pre-NCI NPAT over average equity (company definition, FY26 AR), ROE was 5.3% in FY26 and 50.3% in FY25; ROA was 4.0% and 34.4%. A third-party summary (Quartr) reports FY26 ROE of 8%, consistent with the attributable-basis calculation above.
ROIC: 0.23% on S&P's definition (FY26). Not meaningful for this model.
Interest coverage: (PBT + finance costs) / finance costs was ≈37.5x in FY26 and ≈45.6x in FY25. S&P reports 2.33x on its operating-income basis.
Net debt/EBITDA: Not meaningful (net cash) for FY25–FY26. FY24 net debt was A$135.9m against S&P EBITDA of A$26.1m, about 5.2x.
Asset turnover: 0.10x (S&P, FY26).
Cash conversion cycle: Not applicable (no inventory or trade-receivable cycle in the industrial sense).
Critical observation on book value per share. The company's headline "net assets per share" (A$2.96 FY26; A$2.99 FY25) equals total equity including NCI divided by shares on issue. Equity attributable to OBL shareholders is A$676.6m, or about A$2.34 per share. The company also reports:
-
"book value of investments per share": A$2.25 (FY25: A$2.18)
-
"NTA per share": A$2.08 (FY25: A$1.94)
The 1H26 release cited "total book value per share" of A$3.20, which is a non-IFRS metric including off-balance-sheet fair values. Investors comparing price to book should be explicit about which measure is used.
Operating KPIs (company, non-IFRS)
FY24 fee income is as cited in the FY25 release ("from A$25m to A$30m"). FY24 AUM is derived from the stated "14% CAGR since FY24" and is approximate.
FY25 opex is derived from "20% below FY25". FY25 commitments are derived from "+38%". FY25 new fair value is derived from "+A$38.5m".
Other FY26 KPIs:
-
80 completions at 2.3x MOIC and a 105% fair-value conversion ratio
-
deployments A$241.8m (OBL-only A$28.3m)
-
OBL-only cash and receivables A$124.5m
-
OBL-only EBIT A$49.4m
-
pipeline of 43 exclusive term sheets worth an estimated A$407.8m
-
a further A$45.3m of proceeds received after 30 June 2026 at an estimated 5.7x MOIC (4Q26 report)
Trend and inflection commentary
FY22–FY24: the balance-sheet era. Statutory losses accumulated (A$-45.7m, A$-31.7m, A$-87.5m attributable). Net debt rose from A$3m to A$136m as OBL co-funded its own funds with borrowed money. Attributable book value per share fell to A$0.89. The market cap fell from roughly A$1bn (Simply Wall St, May 2022: A$954m) to under A$300m by late 2024.
FY25: the inflection. Fund 9 crystallised legacy fair value at more than 3x MOIC. Debt was repaid, the funds were deconsolidated, NCI shrank from A$544m to A$194m, and attributable equity rose 167%.
FY26: a normalised year. It showed operating leverage (opex -20%, fees +17%) and record activity. Statutory profit, however, depended on fair-value gains. On implied figures, 2H26 posted a statutory loss before NCI of ≈A$38.6m (FY A$45.9m less 1H A$84.5m). A A$42.8m FX translation loss in OCI also trimmed equity. Fee-only economics still do not cover the cost base, though the gap is narrowing.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Metric | FY2025 | FY2026 |
|---|---|---|
Americas segment revenue (AUD Mn) | 7 | 11 |
APAC segment revenue (AUD Mn) | 117 | 10 |
EMEA segment revenue (AUD Mn) | 68 | 95 |
Corporate segment revenue (AUD Mn) | -165 | 2 |
Total segment revenue (AUD Mn) | 27 | 118 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Metric | FY2025 | FY2026 |
|---|---|---|
Americas total segment income (AUD Mn) | 203 | 9 |
APAC total segment income (AUD Mn) | 495 | 83 |
EMEA total segment income (AUD Mn) | 180 | 147 |
Corporate total segment income (AUD Mn) | -218 | 2 |
Group total segment income (AUD Mn) | 660 | 241 |
Results by Segment — Americas fair value gain or loss
| Metric | FY2025 | FY2026 |
|---|---|---|
Americas fair value gain or loss (AUD Mn) | -25 | 5 |
APAC fair value gain or loss (AUD Mn) | 49 | 79 |
EMEA fair value gain or loss (AUD Mn) | 31 | 106 |
Group fair value gain (AUD Mn) | 55 | 280 |
Results by Segment — Americas EBITDA
| Metric | FY2025 | FY2026 |
|---|---|---|
Americas EBITDA (AUD Mn) | 188 | -25 |
APAC EBITDA (AUD Mn) | 460 | 67 |
EMEA EBITDA (AUD Mn) | 127 | 75 |
Corporate EBITDA (AUD Mn) | -240 | -29 |
Group EBITDA (AUD Mn) | 535 | 88 |
Results by Segment — Americas profit before tax
| Metric | FY2025 | FY2026 |
|---|---|---|
Americas profit before tax (AUD Mn) | 185 | -27 |
APAC profit before tax (AUD Mn) | 458 | 66 |
EMEA profit before tax (AUD Mn) | 103 | 38 |
Corporate profit before tax (AUD Mn) | -250 | -29 |
Group profit before tax (AUD Mn) | 496 | 48 |
Revenue by Segment — Americas operating expenses
| Metric | FY2025 | FY2026 |
|---|---|---|
Americas operating expenses (AUD Mn) | 8 | 19 |
APAC operating expenses (AUD Mn) | 18 | 15 |
EMEA operating expenses (AUD Mn) | 15 | 17 |
Corporate operating expenses (AUD Mn) | 25 | 20 |
Segment Revenue
| Segment | FY26 share of total segment income | FY26 PBT margin on segment income | YoY change in segment income |
|---|---|---|---|
Americas | 3.7% | n/m (loss of A$27m on A$9m income) | -96% |
APAC | 34.4% | 79.5% | -83% |
EMEA | 61.0% | 25.9% | -18% |
Corporate | 0.8% | n/m | n/m |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue S&P standardised (AUD Mn) | 31.03 | 21.50 | 61.05 | 87.77 | 112.26 |
Gross profit S&P (AUD Mn) | -25.94 | -49.51 | 1.34 | 30.45 | 64.08 |
Operating income S&P (AUD Mn) | -60.85 | -93.09 | -47.35 | -25.52 | 1.78 |
EBITDA S&P (AUD Mn) | 8.84 | 6.68 | 26.07 | 533.66 | 37.30 |
Profit before tax (AUD Mn) | -1.79 | -3.81 | 9.51 | 495.52 | 48.17 |
Net profit attributable to members (AUD Mn) | -45.65 | -31.66 | -87.52 | 349.80 | 53.70 |
Basic EPS (AUD) | -0.17 | -0.12 | -0.31 | 1.2315 | 0.1858 |
Diluted EPS (AUD) | -0.17 | -0.12 | -0.31 | 1.2257 | 0.1846 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 | 0 |
Income Statement
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total income statutory (AUD Mn) | 184.5 | 651.2 | 182.2 |
Profit after tax before NCI (AUD Mn) | 30.5 | 416.8 | 45.9 |
Profit attributable to NCI (AUD Mn) | 118.0 | 67.0 | -7.8 |
Revenue from ordinary activities per Appendix 4E definition (AUD Mn) | 82.9 | 68.0 | 106.5 |
Financial Analysis
| Line item | AUD K |
|---|---|
Revenue from contracts with customers | 96,312 |
Interest revenue | 10,156 |
Net gain on litigation investments (financial assets) | 61,920 |
Net gain on derecognition (intangibles) | 7,037 |
Net gain on purchased claims | 5,566 |
Share of associates | 222 |
Other income | 1,022 |
Total income | 182,235 |
Finance costs | 1,322 |
Amortisation of claims portfolio | 35,073 |
Depreciation | 4,012 |
Employee benefits | 51,160 (down 16%) |
Corporate and office | 13,541 (down 35%) |
Other | 7,917 |
Impairment and adverse costs | 12,733 |
Expected credit loss | 1,646 |
Fair-value adjustment on warrants | 6,660 |
Profit before tax | 48,171 |
Income Statement (FY2025–FY2026)
| Metric | FY2025 | FY2026 |
|---|---|---|
Litigation investment proceeds (AUD Mn) | 235.5 | 350.5 |
Proceeds from secondary market transactions (AUD Mn) | 294.7 | 0 |
Management fees (AUD Mn) | 30.3 | 35.4 |
Interest revenue and other (AUD Mn) | 33.2 | 2.4 |
Total gross revenue (AUD Mn) | 593.7 | 388.3 |
Less third party interest (AUD Mn) | -106.8 | -244.9 |
Platform expenses (AUD Mn) | -85.9 | -72.6 |
Litigation costs (AUD Mn) | -58.5 | -47.8 |
Profit before tax consolidated (AUD Mn) | 495.5 | 48.2 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin S&P (%) | -83.61 | -230.31 | 2.19 | 34.70 | 57.08 |
Operating margin S&P (%) | -196.13 | -433.03 | -77.56 | -29.08 | 1.58 |
EBITDA margin S&P (%) | 28.5 | 31.1 | 42.7 | 608.0 | 33.2 |
Pretax margin S&P (%) | -5.78 | -17.73 | 15.58 | 564.59 | 42.91 |
Net margin S&P (%) | -147.12 | -147.27 | -143.37 | 398.56 | 47.83 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 1,075.0 | 1,135.0 | 1,237.0 | 1,185.9 | 1,122.5 |
Cash and equivalents (AUD Mn) | 158.97 | 117.02 | 135.88 | 180.29 | 158.61 |
Borrowings excluding leases (AUD Mn) | 148.00 | 181.64 | 254.81 | 19.50 | 35.40 |
Lease liabilities (AUD Mn) | 13.93 | 17.94 | 16.98 | 13.03 | 9.89 |
Total debt including leases (AUD Mn) | 161.93 | 199.58 | 271.80 | 32.53 | 45.29 |
Net cash or net debt (AUD Mn) | -2.96 | -82.56 | -135.92 | 147.76 | 113.32 |
Goodwill (AUD Mn) | 95.57 | 103.30 | 100.89 | 112.91 | 104.41 |
Equity attributable to members (AUD Mn) | 328.89 | 348.85 | 250.72 | 668.59 | 676.64 |
Non-controlling interests (AUD Mn) | 410.61 | 435.44 | 544.21 | 194.20 | 181.95 |
Total equity (AUD Mn) | 739.50 | 784.29 | 794.93 | 862.78 | 858.59 |
Net working capital (AUD Mn) | 16.75 | 163.00 | 138.15 | 111.82 | 92.53 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -74.55 | -130.43 | -87.88 | 17.09 | -18.34 |
Capital expenditure (AUD Mn) | -1.85 | -0.73 | -0.09 | -0.04 | -0.13 |
Free cash flow (AUD Mn) | -76.40 | -131.16 | -87.96 | 17.05 | -18.48 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on attributable equity (%) | -13.82 | -9.34 | -29.19 | 76.10 | 7.98 |
ROA attributable NPAT over average total assets (%) | -4.26 | -2.87 | -7.38 | 28.87 | 4.65 |
Current ratio (x) | 1.06 | 2.57 | 2.07 | 1.71 | 1.70 |
Total debt to total equity (x) | 0.22 | 0.25 | 0.34 | 0.04 | 0.05 |
Attributable book value per share (AUD) | 1.22 | 1.25 | 0.89 | 2.32 | 2.34 |
Net assets per share including NCI (AUD) | 2.75 | 2.81 | 2.81 | 2.99 | 2.96 |
Key Financials
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Management fee income (AUD Mn) | 25.0 | 30.3 | 35.4 |
Assets under management (AUD Bn) | 4.5 | 5.2 | 5.9 |
Returns & Leverage Ratios and Margin Analysis (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Cash operating expenses (AUD Mn) | 83.9 | 67.1 |
Cost coverage fee income over cash opex (%) | 36 | 53 |
New commitments (AUD Mn) | 516.1 | 712.2 |
New fair value added (AUD Mn) | 525.9 | 564.4 |
Cash investment proceeds excluding secondaries (AUD Mn) | 235.5 | 350.5 |
Permanent headcount | 167 | 156 |
Revenue by Region
| Metric | FY2025 | FY2026 |
|---|---|---|
Americas revenue from contracts with customers (AUD K) | 7,568 | 12,239 |
APAC revenue from contracts with customers (AUD K) | 2,802 | 8,732 |
EMEA revenue from contracts with customers (AUD K) | 38,153 | 71,613 |
Corporate revenue from contracts with customers (AUD K) | 6,463 | 3,728 |
Total revenue from contracts with customers (AUD K) | 54,986 | 96,312 |
Revenue by Region — EMEA claims portfolio revenue
| Metric | FY2025 | FY2026 |
|---|---|---|
EMEA claims portfolio revenue (AUD K) | 34,533 | 67,556 |
Americas claims portfolio revenue (AUD K) | 0 | 1,419 |
Americas management service and transaction fees (AUD K) | 7,568 | 10,820 |
APAC management service and transaction fees (AUD K) | 2,802 | 8,732 |
EMEA management service and transaction fees (AUD K) | 3,620 | 4,057 |
Corporate management service and transaction fees (AUD K) | 6,463 | 3,728 |
Revenue by Region — Americas net gain on derecognition
| Metric | FY2025 | FY2026 |
|---|---|---|
Americas net gain on derecognition (AUD K) | 6,978 | 0 |
APAC net gain on derecognition (AUD K) | 1,844 | 295 |
EMEA net gain on derecognition (AUD K) | 17,677 | 6,742 |
Region Overview
| Region | Contract revenue YoY | Segment PBT FY26 | Assessment |
|---|---|---|---|
Americas | +62% | A$-27m | Fastest-growing fee base (fees +43%). Loss-making on allocation of costs and limited fair-value gains. Largest market for commercial litigation finance (US commitments US$2.8bn in 2025 per Westfleet). |
APAC | +212% | A$66m | Fees tripled from a low base. Strong fair-value gains (A$79m). The class-action ecosystem remains supportive. |
EMEA | +88% | A$38m | Largest revenue contributor. Driven by enforcement and claims-portfolio completions. Amortisation-heavy. |
Corporate | -42% | A$-29m | Shrinking cost centre |
Capital Markets
| Measure | Value | Source / date |
|---|---|---|
Last verified close | A$1.40 | 18 Sep 2026 (S&P via StockAnalysis); A$1.47 intraday on 22 Sep 2026 |
52-week range | A$1.35 – A$1.895 | StockAnalysis, Aug 2026 |
1-year change | -23.3% | 52 weeks to ~19 Sep 2026 (S&P) |
1-year change at results date | ~-10% | 12 months to 27 Aug 2026 (Motley Fool) |
Fund 9 announcement reaction | ~+40% (A$0.965 to ~A$1.35–1.385) | 18 Dec 2024 (ShareCafe; Motley Fool) |
5-year change | Market cap was ~A$954m in May 2022 (Simply Wall St) versus ~A$405m now, a fall of roughly 57% in capitalisation. | Approximate |
Beta (5Y) | 0.42 | S&P |
Per-Share Data and Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Basic EPS (AUD) | -0.17 | -0.12 | -0.31 | 1.2315 | 0.1858 |
Attributable book value per share (AUD) | 1.22 | 1.25 | 0.89 | 2.32 | 2.34 |
Net assets per share including NCI (AUD) | 2.75 | 2.81 | 2.81 | 2.99 | 2.96 |
Shares on issue (M) | 268.64 | 278.62 | 282.55 | 288.43 | 289.64 |
Valuation Multiples
| Multiple | OBL | Basis |
|---|---|---|
P/E (trailing) | 7.6x | S&P (attributable EPS A$0.1858) |
P/B (total equity incl. NCI) | 0.47x | S&P; versus company net assets per share A$2.96 |
P/B (attributable equity) | 0.60x | Analyst: A$405.5m / A$676.6m |
P/TBV | 0.71x | S&P |
Price / book value of investments per share | 0.62x | Analyst: A$1.40 / A$2.25 |
EV/Sales | 4.2x | S&P |
EV/EBITDA | 11.6x | S&P |
Earnings yield | 13.2% | S&P |
Capital Instruments
| Instrument | Amount (30 Jun 2026) | Maturity | Recourse |
|---|---|---|---|
Fund 8 facility (borrowings) | A$35.4m carrying value; A$38.2m drawn | Not disclosed in extract | Non-recourse to the Group, except insurance, Fund 8 assets and a capped standby equity commitment |
Lease liabilities | A$9.9m | Various | Group |
Warrants (Ares) | A$29.5m fair-value liability (A$35m equivalent) | Exercisable from the 2nd to 5th anniversary of the transaction date | Expected equity settlement |
Corporate debt | Nil | Repaid in FY25 | — |
Analyst Conclusions
Management guidance
Omni Bridgeway does not issue earnings guidance. Management's stated outlook is:
-
demand is expected to continue in all markets, with litigation funding viewed as non-cyclical and uncorrelated (FY26 AR);
-
the pipeline is elevated, at 43 term sheets worth an estimated A$407.8m, and terms on new commitments are improving;
-
the flagship fund programme is fully raised;
-
A$45.3m of proceeds was received after 30 June 2026 at ~5.7x MOIC;
-
the ambition is 70% cost coverage by 2028.
Consensus growth expectations are not available from verified sources.
Bull case
-
Operating leverage plus carry. If fees rise from A$35m towards A$47m while opex stays near A$67m, cost coverage reaches 70%. Carried interest from Funds 6 and 4/5 (75% retained for shareholders) then adds a high-margin earnings stream on top of co-investment returns.
-
Deep discount to book. At 0.60x attributable book and 0.62x book value of investments per share, the market implies large markdowns. Yet FY26 completions converted at 105% of fair value, and the Ares transaction cleared at a c.80% fair-value conversion. A secondary-market "mark" exists well above the current price.
-
Record origination in a consolidating market. Commitments of A$712m (+38%) and a new US$1bn flagship position OBL as one of 12–15 funders driving the market (Westfleet). Supply-side exits improve pricing.
Bear case
-
Earnings quality. FY26 statutory profit was smaller than the A$61.9m of unrealised and realised fair-value gains. 2H26 implied a statutory loss before NCI. Statutory OCF was negative (-A$18.3m). The market may continue to discount Level 3 valuations.
-
FX and duration drag. AUD-reported values are exposed to USD and EUR moves (A$48.7m OCI loss in FY26). Court delays, as experienced industry-wide, can erode IRRs and delay carry.
-
Scale and dilution. At a ~A$0.4bn market cap, OBL competes for capital and talent with multi-trillion-dollar managers. Ares warrants (A$35m equivalent) and new executive equity plans add dilution. The Executive Plan's 12.5% ROE hurdle highlights how far current returns (5–8%) are from management's own target.
Catalysts and monitorables (next 12 months)
| Catalyst | Expected timing | What to watch |
|---|---|---|
| 2026 AGM (Executive Plan vote; CEO participation resolution) | Late October 2026 | Vote outcome; any "strike" on remuneration |
| 1Q27 Investment Portfolio Report | Late Oct / Nov 2026 | Proceeds, MOIC, commitments, pipeline conversion |
| Finalisation of >US$300m Series II subscriptions | FY27 | Fee-paying AUM growth |
| Ares warrant exercisability window opens | From the 2nd anniversary of the transaction date (~Dec 2026 – Apr 2027) | Exercise, dilution, strategic signal |
| 1H27 results | ~Feb 2027 | Cost coverage trajectory towards 70%; cash carry; FX impact |
| Sidecar capital (~A$175m in diligence) | FY27 | Structured-capital traction under the new NY leadership |
| Regulatory developments (UK PACCAR fix, EU TPLF, US disclosure and tax) | Ongoing | Any adverse rule changes |
| Board renewal | FY27 | Addition of independent directors |
Concluding analyst verdict
Omni Bridgeway enters FY27 in the strongest corporate condition of its recent history.
-
It carries no corporate debt.
-
Its cost base is a fifth smaller than a year ago.
-
It holds a fully subscribed US$1bn flagship programme.
-
FY26 delivered record commitments and proceeds.
-
Its realised investment performance remains distinctive: a 2.3x MOIC and 105% fair-value conversion across 80 completions.
The Fund 9 transaction with Ares was strategically decisive. It repaired the balance sheet, demonstrated that sophisticated capital will pay near fair value for OBL-originated portfolios, and repositioned the company as a capital-light manager of legal assets.
The market's scepticism is nonetheless rational on three counts:
-
Fee coverage. Statutory profitability still rests on fair-value accounting, and fee income covers only about half of operating costs.
-
Cash flow. Reported operating cash flow is negative, and FX translation can erase a year's profit at the comprehensive-income level, as it did in FY26.
-
Returns. Returns on attributable equity (≈8%) remain below both the 12% discount rate used to value the book and the 12.5% floor in management's own incentive plan.
The share price, near A$1.40 and roughly 0.6x attributable book, reflects those doubts more than it reflects the platform's realised track record.
The investment case therefore hinges on a measurable glide path. Evidence would be:
-
cost coverage moving from 53% towards the 70% target by 2028;
-
cash carried interest building from the A$6.6m base;
-
continued fair-value conversion at or above 100%; and
-
disciplined capital management, including potential buybacks at a deep discount to book once cash generation allows.
Execution in FY26 was credible on every target set. If FY27 shows similar delivery while the post-balance-date proceeds (A$45.3m at ~5.7x) and the A$407.8m pipeline convert, the discount to book should narrow.
Verdict: a fundamentally improved, under-valued but still "show-me" story. The key monitorables are cost coverage, cash carry and FX.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Education | Background | Other listed boards (past 3 yrs) | Independence |
|---|---|---|---|---|---|---|
Michael Green | Non-Executive Director and Chairman | Apr 2023 | BA (Hons) Economics, University of Exeter | 20+ years in global investment management. International CEO of Morgan Stanley Investment Management and of American Century Investments. Co-opted member of London CIV Investment Oversight Committee (2020–23). | Chair and Independent Trustee, Lloyd's of London Pension Scheme (from May 2007) | Independent |
Raymond van Hulst | Managing Director and CEO | Executive Director Apr 2020; CEO Oct 2023 | MBA (INSEAD); Masters in Management (University of Groningen) | ~25 years in legal finance. At Omni Bridgeway since 2002. Established six institutionally backed funds, including the IFC DARP JV and the Ares continuation fund. Led the ROLAND acquisition (2017) and the IMF Bentham–Omni merger (2019). Previously ABN AMRO Structured Finance (India and Europe). | Nil | Executive |
Karen Phin | Non-Executive Director; Chair of Nomination & Remuneration Committee | Aug 2017 | BA, LLB (Hons), University of Sydney; FAICD | 25+ years in capital markets advisory. MD and Head of Capital Advisory, Citigroup ANZ. MD at UBS (13 years). Senior Specialist at ASIC. | NED ARB Corporation (from Jun 2019); NED Supply Network (from Sep 2025); Takeovers Panel member (since 2015) | Independent |
Christine Feldmanis | Non-Executive Director | Nov 2018 | BCom (Wollongong); Master of Applied Finance (Macquarie); FAICD; CPA; F Fin | 30+ years in finance and investment. Former MD of an ASX-listed boutique funds-management incubator. Former CFO, NSW Treasury Corporation. | NED Bell Financial Group (from Feb 2020); NED United Malt (Jan–Nov 2023) | Independent |
Directors' Remuneration
| Body | Meetings held |
|---|---|
Board | 10 |
Audit & Risk Committee | 4 |
Nomination & Remuneration Committee | 6 |
Corporate Governance Committee | 4 |
Executive Leadership Team
| Name | Title | Since | Background |
|---|---|---|---|
Raymond van Hulst | MD & CEO | CEO Oct 2023 | See above |
David Breeney | Global CFO | 1 Mar 2025 | 12+ years at Challenger Ltd in senior finance roles. Joined OBL 2023 as Global Head of Financial Control; Deputy CFO Oct 2024. BA (Hons) Economics (UWE); FCA (ICAEW); CA ANZ. |
Jeremy Sambrook | Global General Counsel & Company Secretary | 18 Jan 2016 | Corporate lawyer (UK, Hong Kong, Channel Islands, Australia); LLB (Bristol) |
Peter Galgay | Head of Commercial Strategy & Capital Solutions (New York) | Apr 2026 | Focus on large-scale structured finance and alternative investment solutions for legal assets (not KMP) |
Nathan Kandapper | Global Head of Investor Relations | — | (not KMP) |
Executive Leadership Team (Annual)
| Name | Currency | Salary & fees | Cash bonus | Super/pension | Employee entitlements | Share performance rights | Total FY26 | Total FY25 | Performance-related % FY26 |
|---|---|---|---|---|---|---|---|---|---|
R. van Hulst | CHF | 701,876 | 0 | 48,106 | 16,246 | 293,085 | 1,059,313 | 874,818 | 28% |
D. Breeney | AUD | 450,000 | 0 | 30,000 | 13,534 | 135,923 | 629,457 | 216,770 (part-year) | 22% |
J. Sambrook | AUD | 485,800 | 0 | 30,000 | -560 | 337,587 | 852,827 | 832,770 | 40% |
M. Green | GBP | 75,000 | 0 | 0 | 0 | 0 | 75,000 | 75,000 | 0% |
K. Phin | AUD | 120,536 | 0 | 14,464 | 0 | 0 | 135,000 | 135,000 | 0% |
C. Feldmanis | AUD | 135,000 | 0 | 0 | 0 | 0 | 135,000 | 135,000 | 0% |
Major Shareholders
| Holder | Shares |
|---|---|
R. van Hulst | 6,355,129 |
M. Green | 207,115 |
C. Feldmanis | 135,000 |
K. Phin | 102,266 |
J. Sambrook | 8,446 |
D. Breeney | 0 |
KMP total | 6,807,956 (≈2.4% of 289.6m) |
Major Shareholders — Perpetual Limited
| Holder | Stake | Date / source | Status |
|---|---|---|---|
Perpetual Limited (incl. TSW) | 13.657% (39.39m shares), with further purchases of ~5.48m shares reported to 31 Oct 2025 | Form 604, 23 Oct 2025 (FilingReader); Simply Wall St | — |
Retail Employees Superannuation Trust (REST) | ~9.5% | Simply Wall St, Sep 2024 | — |
Samuel Terry Asset Management | ~5.8% (Sep 2024); bought a further 3.8m shares in Jun 2025 | Simply Wall St | — |
Brightlight Capital | Became substantial 16 Apr 2026; ceased 16 Jul 2026 | Form 605 (Kalkine) | Exited substantial |
Amitell Capital | Sold ~2.0m shares, Sep 2025 | Simply Wall St | Reduced |
Ares Management | Warrants equivalent to A$35m; not yet exercisable | FY26 AR | Potential holder |
R. van Hulst | ~2.2% | FY26 AR | Insider |
Competitive Landscape
Key Competitors
| Competitor | Listing | Segment overlap | Scale indicator | Positioning vs OBL |
|---|---|---|---|---|
Burford Capital | NYSE / LSE: BUR | Global commercial litigation, asset management, enforcement, monetisation | FY25 (USD): new definitive commitments US$872m (+39%); consolidated capital provision income US$477m; consolidated net income US$72m; consolidated cash receipts US$770m; cash and securities US$656m (Burford DEF 14A, 2026) | Largest peer; balance-sheet-heavy with bond funding; higher US concentration and large YPF exposure |
Litigation Capital Management (LCM) | AIM: LIT | APAC and UK commercial, class actions, arbitration | — | Smaller; Australian heritage; direct competitor in APAC class actions |
Harbour Litigation Funding | Private (UK) | UK and European commercial | — | Major UK competitor |
Therium Capital Management | Private (UK) | UK, international commercial and arbitration | — | — |
Fortress Investment Group (legal assets) | Private (Mubadala-owned) | US, global legal assets, IP | — | Deep-pocketed multi-strategy entrant |
Parabellum Capital | Private (US) | US commercial and IP | — | US portfolio funder |
Longford Capital | Private (US) | US commercial; law-firm financing | — | US competitor |
Bench Walk Advisors | Private (US) | US and global commercial | — | US competitor |
CASL (Litigation Lending Services and peers) | Private (Australia) | Australian class actions | — | APAC class-action competitor |
Woodsford | Private (UK) | UK and EU collective actions | — | EU/UK collective-action competitor |
Deminor | Private (Belgium) | EU litigation funding, enforcement and recovery | — | Competes in EMEA enforcement and recovery |
Nivalion | Private (Switzerland) | DACH and EU litigation funding | — | EMEA competitor |
Augusta Ventures | Private (UK) | UK, international commercial | — | UK competitor |
“—” = not publicly disclosed.
Peer Comparison FY2026
| Metric | Omni Bridgeway (FY26, A$) | Burford Capital (FY25, US$) |
|---|---|---|
New commitments | A$712.2m (+38%) | US$872m (+39%) |
Investment proceeds / cash receipts | A$350.5m (consolidated) | US$770m (consolidated) |
Fee income | A$35.4m (+17%) | — |
Statutory net income | A$45.9m (attributable A$53.7m) | US$72m consolidated |
Corporate leverage | Net cash; no corporate debt | US$500m 7.50% notes due 2033 issued Jul 2025; ~0.9x debt/net tangible equity (3Q25) |
AUM | A$5.9bn | — |
Recent Developments
*Litigation and regulatory actions against
*Layoffs: headcount fell from 167 to 156 in FY26.



